Clinical Trial Update: Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets

View source ↗

Summary

Completed bioequivalence study evaluating Glucotrol XL 2.5 mg extended-release tablets in adults with type 2 diabetes mellitus. The trial assessed bioequivalenc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucotrol XL 2.5 mg tablets (glipizide extended-release)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Non-Insulin-Dependent, Hyperglycemia | Status: COMPLETED